Lynn Kohlmeier, MD

Spokane Osteoporosis and Endocrinology
Spokane, Washington, United States

Disclosure information not submitted.

Presentation(s):

• ORF16-07 - Palopegteriparatide Treatment in Adults with Hypoparathyroidism: Final Results of the Phase 3 PaTHway Trial

  Saturday, June 13, 2026
  2:45 PM - 3:00 PM CT